FDA NEWS

FDA reviewing arthritis drugs for cancer link - CNBC
WASHINGTON - Federal regulators are investigating whether a group of best-selling arthritis drugs made by Abbott Laboratories, Schering-Plough Corp. and other companies heighten the risk of cancer in youngsters. The Food and Drug Administration said
Source: www.cnbc.com

FDA probes cancer in children given arthritis drugs - Reuters
WASHINGTON (Reuters) - U.S. health officials are investigating whether drugs used to treat rheumatoid arthritis and Crohn's disease are linked to cases of lymphoma and other cancers in children and young adults, the Food and Drug Administration said
Source: www.reuters.com

Indevus expects FDA to request additional Nebido safety data - Forbes
BOSTON (Thomson Financial) - Indevus Pharmaceuticals Inc. Wednesday said it expects the Food and Drug Administration to formally request additional safety data prior to approving Nebido, a long-acting testosterone depot preparation. Indevus said it
Source: www.forbes.com

Draeger’s new ventilator gets FDA nod - Philadelphia Inquirer
Draeger Medical Inc. announced today that it has received clearance from the Food and Drug Administration to market a new ventilator to the U.S. market. The device, called the Carina ventilator, has both invasive and non-invasive capabilities. The
Source: www.philly.com

FDA probes cancer in kids given arthritis drugs - Reuters UK
WASHINGTON (Reuters) - U.S. health officials are investigating whether drugs used to treat rheumatoid arthritis and Crohn's disease may have contributed to cases of lymphoma and other cancers in children and young adults, the Food and Drug
Source: uk.reuters.com

Indevus Pharma Slides on FDA Delay - Street.Com
Efforts by Indevus Pharmaceuticals IDEV to land U.S. approval for a long-acting testosterone have been delayed by two years, news that sent the stock falling to a new 52-week low Wednesday morning. The Lexington, Mass.-based specialty pharmaceutical
Source: www.thestreet.com

FDA to study if link exists between childhood cancer and Abbott's - Chicago Tribune
Due to a possible link to certain cancers in children, the U.S. Food and Drug Administration this morning said it was conducting a safety review of Abbott Laboratories ' blockbuster rheumatoid arthritis drug Humira and similar drugs known as "tumor
Source: www.chicagotribune.com